This is further to our letter dated November 04, 2025, intimating the date of the Board Meeting for the approval of Un-audited (Standalone and Consolidated) Financial Results for the quarter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, with a clean limited review report from auditor S S Kothari Mehta & Co. LLP. Standalone revenue from operations jumped to Rs. 1,191.01 lakhs in Q2 FY26 from Rs. 388.57 lakhs in Q2 FY25 (around 3x), while H1 FY26 standalone revenue rose to Rs. 1,418.03 lakhs from Rs. 636.49 lakhs. Standalone profit after tax for H1 FY26 swung to Rs. 259.81 lakhs from a prior-year loss of Rs. 37,565.18 lakhs, which had been dragged down by a one-time Rs. 37,494.57 lakhs exceptional loss on the demerger of the chemicals business. Consolidated revenue was broadly flat at Rs. 5,085.02 lakhs for H1 FY26, with consolidated PAT of Rs. 489.17 lakhs (down from Rs. 936.50 lakhs).
The company has effectively transitioned post the chemicals demerger, with its continuing businesses now being Investments & Trading and General Engineering Products (via subsidiary Duncan Engineering). Standalone numbers show a strong turnaround, but shareholders should note consolidated profits have moderated versus the prior period, and the clean auditor report means no red flags from the review.